Skip to main content
Contact Info
Dr. Suresh Thareja
Central University of Punjab, Bathinda, Punjab, India
Dr. Suresh Thareja

B.Pharm., M.Pharm. (Pharmaceutical Chemistry), Ph.D., Post Doctorate (USA)

Teaching Experience: 10 years
Research Experience: 13 years
Administrative Experience: Nil
Any Other Experience (Industrial experience): 6.5 Months


Research Area
  • Computer aided drug design and Synthesis of novel chemical entities for the treatment of various disorders including Diabetes and Cancer
  • Natural Products modification
  • Molecular docking and 3D-QSAR studies
Research Interests
  • Computer Aided Drug Design
  • Synthesis
  • Nanoformulations
  • Antidiabetic and anticancer Screening
Research Grants/Projects
  • Design, Synthesis and Evaluation of Novel Chromen based Aromatase Inhibitors for the Treatment of Hormone Dependent Breast Cancer (RSM, CUP, Bathinda)
  • Pre-Clinical Development of Patented Biphenyl-Thiazolidinediones for the Effective Management of Type 2 Diabetes Mellitus (ICMR, New Delhi)
  • Development and Characterization of Natural Biodegradable Polysaccharides Based Mulitparticulate Formulations for Effective Targeting to Colon for the Management of Inflammatory bowel diseases (AICTE, New Delhi)
  • Computer aided design, synthesis and study of novel PTP-1B inhibitors as potential antidiabetic agents (UGC, New Delhi)


Professional Affiliation
  • Member, American Chemical Society, USA
  • Life member Indian Pharmacy Graduates' Association (IPGA),  India
  • Frontiers Section Editor (Medicinal Chemistry), Anticancer agents in Medicinal Chemistry (IF:2.505)
  • Frontiers Section Editor (Medicinal Chemistry), Letters in Drug Design and Discovery (IF:1.169)
Professional Recognition/Awards/Scholarships
  • Published research findings in Chemical Reviews (Impact factor: 60.622).
  • Recipient of Raman Post-Doctoral Fellowship from UGC, New Delhi, India.
  • Recipient of Senior Research Fellowship from Indian Council of Medical Research (ICMR) New Delhi, India.
  • Best Research paper award in IPC-2008 held at New Delhi.
  • Recipient of $1100 for publication in American Chemical Society
  • Felicitated by Governing body (Syndicate) of Panjab University in 2009.
  • First Position with Distinction in M. Pharm (Pharmaceutical Chemistry).
  • Recipient of GATE fellowship for M.Pharm. from AICTE, New Delhi.
Research Collaboration
  • Dr. Akhlesh Jain, Guru Ghasidas Central university, Bilaspur, C.G., India
  • Prof. P. K. Mishra, National Institute for Research in Environmental Health, Bhopal, India
Articles: 02
Books: 01
Book Chapters: 02


Research Guidance
  • Ph.D. Guidance: 02
  1. Design, synthesis and biological evaluation of novel arylidene-thiazolidinedione derivatives for the management of diabetic complications (Sant Kumar Verma, Ph.D. Awarded).
  2. Design, synthesis, and evaluation of novel biphenyl analogues as aromatase inhibitors for the treatment of breast cancer (Laxmi, Ph.D. (pre-submission).
  • M. Pharm. Guidance: 04
Conference/ Workshops/Seminars Attended
University Level:02
National: 10
International: 04


Conference/ Workshops/Seminars Organised
University Level: 02
National Level: 02
International Level:01


Peer Recognition
  • Frontiers Section Editor (Medicinal Chemistry), Anticancer agents in Medicinal Chemistry (IF:2.505)
  • Frontiers Section Editor (Medicinal Chemistry), Letters in Drug Design and Discovery (IF:1.169)
Invited Talks/ Resource Person
Chairperson, Technical Session, ISFCON International Conference (2021)
Invited talk in the Online AICTE Sponsored Short Term Training Programme (STTP) held at Columbia Institute of Pharmacy, Raipur (2021)
Invited talk in faculty development program held at GLA University, Mathura (2020)
Patent Filed/ Published
Thareja S. et al. ,“Synthesis and uses of 5-[4-(2-biphenyl-4-yl-2- oxo-ethoxy)-benzylidene]-thiazolidine-2, 4-dione derivatives” (PCT InternationalPublication No. WO 2019/016826).
Thareja S. et al., “Synthesis and uses of 5-[4-(2-biphenyl-4-yl-2- oxo-ethoxy)-benzylidene]-thiazolidine-2, 4-dione derivatives” (Indian Patent Application No. 201721025305)
Thareja S. et al. “Dual inhibitors of aldose reductase and PTP 1B, methods of making and uses thereof” (Indian Patent Application No. 201921023832).
Thareja S. et al., “Novel (Z)-5-((E)-2-Methyl-3- Phenylallylidene)-2,4-Dioxothiazolidine-3-Carboxylic Acid as Dual Inhibitor of AR and PTP 1B, Synthesis and Uses Thereof” (Indian Patent Application No. 201921024452).
Contribution Towards Institutional Building
Member, Research Park Cell, CUPB
Member, School Board, School of Health Sciences, Central University of Punjab (CUP).
Member, Academic and Administrative Committee, DPSNP, CUPB
Coordinator, AICTE and PCI, DPSNP, CUPB

H-Index: 18

I-10 index: 30

Total citations:1287

Curricular Development
Member, Curriculum Design and Development Committee, DPSNP, CUPB